semaglutide
65% Drop in Heavy Drinking Using Obesity Treatment
A recent pilot study found a 63% reduction in heavy drinking days when adults with obesity received a GLP-1 agonist, delivering a double win for weight loss and alcohol use disorder. Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified